MONTREUX EQUITY PARTNERS IV LP
Insider CIK 1423641 · EPRS 10% owner · GKOS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GKOS GLAUKOS Corp | S Sale | 2016-02-25 | 2016-02-26 | 70,000 | $16.16 | $1.13M | 3,209,812 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 630,788 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 1,415,449 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 783,740 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 288,429 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 37,186 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 15,860 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 108,360 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 161,406 | — | $0 | 161,406 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 3,118,406 | — | $0 | 3,118,406 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | S Sale | 2015-02-06 | 2015-02-09 | 100,000 | $5.01 | $501.0K | 1,671,400 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | S Sale | 2015-02-05 | 2015-02-09 | 67,316 | $4.97 | $334.6K | 1,771,400 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | S Sale | 2015-02-04 | 2015-02-05 | 5,684 | $4.95 | $28.1K | 1,838,716 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | S Sale | 2015-02-03 | 2015-02-05 | 47,000 | $4.99 | $234.5K | 1,844,400 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | S Sale | 2015-01-26 | 2015-01-28 | 38,516 | $6.47 | $249.2K | 1,891,400 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | S Sale | 2015-01-23 | 2015-01-26 | 8,400 | $6.27 | $52.7K | 1,929,916 | SEC↗ |
| EPRS EPIRUS Biopharmaceuticals, | S Sale | 2015-01-22 | 2015-01-26 | 14,130 | $6.30 | $89.0K | 1,938,316 | SEC↗ |